chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt recvd Hep B vax on 29JUL92 & several hrs later, devel lightheadedness, weakness, tiredness, & nausea; sx persisted for approx 24 hrs, then remitted;
ITCHY SKIN IRRITATION ON LEFT ARM; LOSS OF APPETITE; FATIGUE(LOW ENERGY LEVELS); URINARY INCONTINENCE; FEVERISH; ACHY FOREHEAD; ACHY EYES; MILD RASH; This spontaneous report received from a patient concerned a 74 year old female. The patient's height, and weight were not reported. The patient's past medical history included: appendectomy, and concurrent conditions included: antibiotic allergy. The patient experienced drug allergy when treated with epinephrine, promethazine, and tramadol.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 08-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On SEP-2021, the patient experienced mild rash. On 08-SEP-2021, the patient experienced urinary incontinence. On 08-SEP-2021, the patient experienced achy eyes. On 08-SEP-2021, the patient experienced feverish. On 08-SEP-2021, the patient experienced achy forehead. On 09-SEP-2021, the patient experienced loss of appetite. On 09-SEP-2021, the patient experienced fatigue (low energy levels). On 13-SEP-2021, the patient experienced itchy skin irritation on left arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from urinary incontinence, achy eyes, feverish, and achy forehead on 09-SEP-2021, loss of appetite, and fatigue(low energy levels) on 11-SEP-2021, and mild rash on SEP-2021, and the outcome of itchy skin irritation on left arm was not reported. This report was non-serious.
I developed a 108.3 degree fever 16 hours after injection. Also swollen lymph glands in left armpit, inflammation on left side of body, headache, extreme fatigue
Transient local reaction to moderna vaccine. Red rash on opposite forearm, measuring 3cm. Occurred 5 days after vaccination, started to fade at 12 days post vaccine but reappeared at day 16 following a loading dose of a new immune suppressant drug called Stelara.
dizziness; hot; This is a spontaneous report received from a non-contactable other healthcare professional. A 56-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6205) via an unspecified route of administration on 24Mar2021 as single dose for COVID-19 immunisation. Medical history included multiple sclerosis and complained of a weakness in her legs that she experiences during her flares. She does mention having to be on 2L oxygen at times when she has a flare. The patient's concomitant medications were not reported. On 24Mar2021, patient began to experience dizziness and hot. She was treated with water and lying in trendelenburg position. Outcome of events was unknown.  No follow up attempts are possible. No further information is expected.
DAY AFTER VACCINE PATIENT HAD SEVERE CRAMPING DOWN LEFT SIDE OF ARM AND BACK. SAID IT FELT LIKE SOMEONE HAD BEAT THEM WITH A SLEDGE HAMMER ON HIS LEFT SIDE.  LASTED FOR 2 DAYS WHERE PATIENT COULD NOT DO ANY NORMAL DAILY ACTIVITY.
This spontaneous report was received medical assistant regarding unspecified number of patients of unknown age and gender. The pertinent medical history of patients and their concurrent conditions were not reported. On an unknown date, unknown number of patients were inadvertently administered with improperly stored RECOMBIVAX HB therapy type, lot dosing details unknown. Concomitant medications were not reported. It was reported that the vaccines administered were subjected to a temperature excursion of 46.7 degrees F for a time frame of 2 hours. It was reported that the vaccines were not subjected to previous temperature excursions. No adverse effects were reported. Product quality complaint (PQC) was not filed. This is one of the two cases received from the same source. Additional information has been requested.
10 second period of lethargy. Pale appearance while sleeping-found by father and responded after 10 second stimulation.
Administered vaccine at 3:52 pm at 3:55 pm patient stated, "my throat is closing" and was dyspneic and appeared panicked. Angioedema present. Administered 0.3 mg epinephrine into left ventro-gluteal IM site. Medical assistant called 911. Then I administered 25 mg Benadryl PO. Recommended to go to ER. Paramedic ambulance arrived at 4:03 pm and took patient into emergency vehicle to evaluate her.  Paramedics reported her vitals were stable at 4:05 pm BP 183/129 HR 93 O2 sat 100% breathing normally bilaterally. no stridor present.  Paramedic unit responded and was to transport the patient to the emergency room. All patient care transferred to paramedics prior to leaving. After patient was stable  she stated she has allergy to claritin.  Left the scene after patient was stabilized at 5:10pm with ambulance still present. The incidence was reported to headquarters before leaving the scene.
Initial unsolicited report received from a healthcare professional via other company (Pfizer) (Manufacturer Report Number: 2016009819) on 06-Apr-2016. This case involves a female patient (age not reported) who was vaccinated with a dose of DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (TDAP) and a dose of DIPHTHERIA AND TETANUS TOXOIDS (Tetanus and Diphtheria Tox, Adult) (batch number, expiry date, route and site of administration: not reported for both vaccines) on an unspecified date. Patient's medical history and concomitant medications were not reported. On an unspecified date, following the vaccination, the patient developed allergy to vaccinations. On an unspecified date, after Tetanus and Diphtheria Tox, Adult vaccine, the patient developed swelling and on an unspecified date after TDAP vaccination the patient developed redness. Laboratory investigations and corrective treatment were not reported. The outcome of the event was not reported. List of documents held by sender: none.
No adverse effects; one separate dose of an improperly stored vaccine, PEDVAXHIB was administered to one separate patient.; Information has been received from a medical assistant, referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported.    On 05-JUN-2019, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) 0.5 milliliter (one dose, lot# R021077, expiration date: 11-JUN-2021, frequency was unknown) intramuscularly for prophylaxis (incorrect product storage). No adverse effect was reported.  The vaccines were exposed to temperature of 34.2 Fahrenheit (F) for 4 hour 54 minutes. The temperature excursion was detected by a data logger. No previous excursions were reported.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-1906USA011674:
nausea; sore arm; fatigue; temperature going up; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), MYALGIA (sore arm), FATIGUE (fatigue) and PYREXIA (temperature going up) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced NAUSEA (nausea), MYALGIA (sore arm), FATIGUE (fatigue) and PYREXIA (temperature going up). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NAUSEA (nausea), MYALGIA (sore arm), FATIGUE (fatigue) and PYREXIA (temperature going up) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.
This spontaneous report as received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. There was no information about the patient's medical history, concurrent conditions and concomitant medication provided. On an unknown date in 2011, the patient was vaccinated with a dose of ZOSTAVAX as recommended for routine adult health maintenance and for the prevention of shingles (dose, route of administration, anatomical location, lot# and expiration date were unknown). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles (onset date was not provided). On an unknown date in 2011 (reported as later in 2011), the patient was treated for a vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. The reporter considered the events to be related to the ZOSTAVAX.
I had a swollen lymph nodes and neck so it shows that there is a cyst and I have to get a CT scan on it; I also had issues with my abdomen.
Immunization error. Pt came in the get School shots. Pt received MMRV instead of Separate MMR and Varicella.
Took the vaccine on 3/29/21 the next day start having adverse reaction to the vaccine. The vaccine was administered on the left side of his upper arm. He start having severe headaches, left arm and hand went numb. Patient also, stated he went back to the emergency room, he was given meds that has not worked to assist with the adverse reactions. He has missed 6 six post days from work due to complications of the vaccination. Currently, his neck hurts really bad and his blood pressure is elevated as now. He was told to do a follow up w/Neurologist regarding his current adverse reactions per his PCP.
He got his 1st dose on 17/Apr/2021 and his second dose on 24Jun2021; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Jun-2021 and was forwarded to Moderna on 25-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He got his 1st dose on 17/Apr/2021 and his second dose on 24Jun2021) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He got his 1st dose on 17/Apr/2021 and his second dose on 24Jun2021). On 24-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (He got his 1st dose on 17/Apr/2021 and his second dose on 24Jun2021) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.     No concomitant medications or treatment details were reported.   Reporter did not allow further contact
Report received from a registered pharmacist regarding a possible adverse event associated with the use of Fluvirin. A 49 year old male patient received vaccination with Fluvirin, lot number E67930KA or E67940KA, on 10/10/00. On 12/2/00, this patient developed right parascapular pain and on 12/6/00 developed right hand weakness and dyscoordination. He has specific weakness of thumb and abduction of fingers with decreased pinch and grip strength. A C-Spine MRI was performed and did not explain symptoms. A MRI of his brain is pending. A tentative diagnosis has been made of brachial plexitis. The patient has a history of hypertension and takes lisinopril. No other information was provided. Attempts to obtain further information were attempted with reporter unable to provide any specific information. Follow up received from reporter on 6/27/01 via telephone. The reporter states that she received follow up information consisting of the following: The patient has not recovered and has regained 70% of his strength in his right arm and shoulder and still experiences pain in the right arm and prescapula requiring daily use of Motrin. The patient is seeing a neurologist who confers with Personage Turner Syndrome. No other information was available, further information requested from the reporter. (OMIC)
Pain n swelling on the injection site on the left arm; Pain n swelling on the injection site on the left arm; This is a spontaneous report received from a contactable consumer (Patient). A 57-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number/ expiration date: unknown) via unspecified route of administration at left arm on 10Feb2021, 01:00 at single dose for COVID-19 Immunization. The patient's medical history included Diabetes dm. Concomitant medications were not reported. No known allergies reported. The patient did not receive any other vaccination within 4 weeks. No Covid-19 prior vaccination and covid tested post vaccination yes. On 12Jun2020 the patient was tested for COVID-19 (Nasal-swab) result negative. On 10Feb2021 at 01:00 PM, the patient had Pain and swelling on the injection site on the left arm. The patient did not receive any treatment for the event. Outcome of the event was not resolved.   Information on the lot/batch number has been requested.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 72-year-old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications.  On or about 04-OCT-2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route were not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced shingles. On an unspecified date, the patient was treated by a physician for shingles. The outcome of the event was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
The right side of my nose, mid way up thru the first part of my eyebrow has been twitching/wuovering since Monday evening 3/16 pretty much non stop. I received covid 19 vaccine step 1 on 3/15
Numbness and tingling left arm from shoulder down to wrist on the back of the arm.
This case was reported by a consumer via call center representative and described the occurrence of local swelling in a 74-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose received in August 2018). In November 2018, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced local swelling and pain in arm. On an unknown date, the outcome of the local swelling and pain in arm were unknown. It was unknown if the reporter considered the local swelling and pain in arm to be related to SHINGRIX. Additional details were reported as follows: The patient received her 1st SHINGRIX injection in August with no side effects. The patient had her 2nd injection early in November 2018 and she still had a bump on her arm and her arm was still sore. The patient had an appointment to see her doctor next month and would inquire about it. The patient was asking is this normal. The patient was asking question regarding how long side effects of SHINGRIX should last. This was all the additional adverse event information provided during the call.
The arm started out with a solid red circle @ the injection site on the day of the injection   Now today, 9 days later it is red, measures 2' x 2' and is warm to the touch.
Vial initially stored in the refrigerator on 18-Aug-2022 and then administered on 19-Sep-2022; No adverse event; Patient received Moderna Covid 19 vaccine 2 days after the 30 day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid 19 vaccine 2 days after the 30 day use by date), PRODUCT STORAGE ERROR (Vial initially stored in the refrigerator on 18-Aug-2022 and then administered on 19-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 7-month-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR9236B) for COVID-19 vaccination.     It was reported that patient had no allergies. Patient had never tested positive for COVID-19.     On 19-Sep-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid 19 vaccine 2 days after the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial initially stored in the refrigerator on 18-Aug-2022 and then administered on 19-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid 19 vaccine 2 days after the 30 day use by date), PRODUCT STORAGE ERROR (Vial initially stored in the refrigerator on 18-Aug-2022 and then administered on 19-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received Moderna Covid 19 vaccine 2 days after the 30 day use by date) and PRODUCT STORAGE ERROR (Vial initially stored in the refrigerator on 18-Aug-2022 and then administered on 19-Sep-2022).    No concomitant medication given.  The monovalent vial was of 2.5 ml size. The vial did not undergo any temperature excursion.  Treatment medications were not provided.
Information was received from a nurse concerning a healthy female with allergy to MSD and DIAZIDE who on 12 APR 2005 was vaccinated with PPV.  The nurse reported that the patient developed erythema and hardness of the injection arm within 24 hours.  The nurse also reported that the erythema and hardness was on the back on the arm of injection.  The patient was treated with warm compresses and BENADRYL at bedtime.  The patient sought unspecified medical attention.  At the time of the report the patient had not recovered.  Additional information was requested.
Patient's entire deltoid area became red, swollen, painful and hot to touch approximately 12 hours after injection. A small blister approximately 3cm from injection site was also noted. He was treated with Tylenol and ice.
After my second dose, I was in the ER twice in one week with a 104° fever, throwing up, coughing, exhausted, etc. However, I was told that those reactions were normal. Then I got my booster shot a few months later, and it was worse. 6 hours after receiving the shot, I became feverish and so exhausted that I couldn't walk. I went to sleep and woke up 4 hours later with a 102° fever, throwing up, severe chills, shortness of breath, lightheadedness, and physical shaking. The next day all of those symptoms worsened, and my fever went up to 105°. The fever fluctuated between 100° and 105° for a week before dropping to 99. I then went to get my return to school covid test and tested positive for COVID. In the days after I tested positive for covid, the symptoms all slowly came back just as severe. I then caught the flu a month later.
Right upper arm inflammation, warm to touch, hardness and bruising. Afebrile. Treating with cool compresses, Tylenol and PO Benadryl.
Information has been received from a pharmacist concerning a female who on an unspecified date was vaccinated with ZOSTAVAX.  Subsequently the patient broke out in "shingles like pox" post vaccination.  The reporter is not interested in VZV Analysis by PCR.  The patients "symptoms" resolved.  At the time of reporting the patient was "okay".  No further information is available.
Complained of feeling faint, lightheaded 2 minutes after receiving 1st dose of vaccine.  She sat down in chair, nearly fainted, then threw up.  She felt weak for remainder of day.  The arm that received the vaccine was extremely sore for 5 days.
Swelling in left hand. Pt received anthrax vaccine 4Feb12 by employee. Pt noticed swelling in left hand, arm used for anthrax, on 5Feb12. Pt came into clinic 6Feb12 to see provider. Pt received medication.
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.